{"name":"Calibr, a division of Scripps Research","slug":"calibr-a-division-of-scripps-research","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPbzBNTWpoUWlPdzFCbXNIYWc3M2dTOGtqZ0lnQ01Qa2pjM00zQWRwQmN0NVZHVnE4YUhPOUtJNUxzaDV2b3ZZUTA0cHVnanhRd3pEczlIV0tUbHZRVDk1TDI1UFR1bThvbEs3Z1pndk1ZT09hQWtNNGZCcTdVbGllbk9Na1Z4N085RGdvenlqc3hzdFBidE1TTVBSRmhvMkE?oc=5","date":"2025-09-04","type":"pipeline","source":"San Diego Business Journal","summary":"Scripps Researchers Co-develop Possible Tuberculosis Treatment - San Diego Business Journal","headline":"Scripps Researchers Co-develop Possible Tuberculosis Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQNGg5STZyTF82U0owdXp6N1RvTVRPX2FrNXBBM2V2eE1CU1dGb3V1a2ZEMTljUzVhbjNHQXJiTExrb2lVOXhzNmZWUXZnNDBEZmlmUFExX3RobDNtMEN5M2k5TUIxdWprZVhlVnJrSWhjUEZUQjFJS25WMTlJUWpSWElRSUJwYm1yNnFF?oc=5","date":"2025-04-09","type":"regulatory","source":"Scripps Research","summary":"FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy - Scripps Research","headline":"FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemoth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPSHZKZjhuVXJGM3ZHX0lJRy1hQjh0cW5OZVhuOTE0UnRybFppNi1TTzFNMC1aZGgwZ2c1dnNfTTZNTU0tOGdweDdLbDFyN1dwR2xjd2h1RGNTM3ZDSkh5TWxJb1BPWWZUMlo0Q1hxWEdWTW92VURkcE40ZGxqZkwwVTMwY3V0V2UwdkplOXExQ0lSMV9SSXRnWWpUVTVKWUcxV1BsSERIVGJFcVlxLVVlV0I2R0VFWlMzRFhMbGs2dVFMcDFXTzNGLXpnZTUtTlRESGFuTkJOWUZEalE?oc=5","date":"2025-04-09","type":"regulatory","source":"News-Medical","summary":"Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases - News-Medical","headline":"Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases - News","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOT3N4bXBCX2JiSHVNa3hYTEh6NW9hY1VEVFpEUTZwam1hcUFuRzQ3SV8tbEdZSTBDUTRpVUNOdEJyeTBvaC1qYVI1WjYtd0VzXzlZaGdfZTFyeTktaGo5V1M2bFBxQnhiYmxCUEtkRnFvZDNNX2szY0FnSFk1cXByMG94YVplVEpjZTg2ZVE2UEg2c0x5TXdxN3lTbTBhaWhqU3RZbkgzbVIxTzJVNE55TDlPU2w0NTdkbzhfS0wwMzRrVUlzOTlEVE9vblNjVVJzV0V3Szl2RUp5dzBSVVVZZ3hJb2x2a2c?oc=5","date":"2024-10-30","type":"pipeline","source":"Business Wire","summary":"Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases - Business Wire","headline":"Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPTXlYQlQ1eHNLRExqN1pQZ29sMC1MZGVldWpaa2VoRDQtZEpwXzNxcUNMdVFyLTFrd3VBTy04eVNkN2djTmRxMGFDMjNBNTUwaVlFXzIyZlRvQWpUOV9ZSWk4cHRLWDRsd1BmcWJQTTZYM0RxcURfajBkdGdaem1EQnZMTzFienZDWDMtNXBYTXlTN3M?oc=5","date":"2023-07-27","type":"deal","source":"Pharmaceutical Technology","summary":"AbbVie, Calibr expand partnership for clinical assets - Pharmaceutical Technology","headline":"AbbVie, Calibr expand partnership for clinical assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPc3gwZ21nQWJMSkRCSEhGSVlCc05fVTN4aXA4MXRUanRWVGF3ZVg2akc5eDE5WlNCMkVZeVNKcHZXR0djOG84LW16RS12cGM0WTNVTWtIOVFfOUJ3VVFSYk1NOWF2WklGaXdKQWpoUWFFdS00bGozcE1wUjFIS3pHcFZ0NEs0MldsdVNvb0M3R0Y?oc=5","date":"2023-04-24","type":"regulatory","source":"Pharma Voice","summary":"Tuberculosis is the world’s deadliest infectious disease — and treatments remain underfunded - Pharma Voice","headline":"Tuberculosis is the world’s deadliest infectious disease — and treatments remain underfunded","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxNV3poNnd2aDB1SFBfeGpkSjRxR2FJOG5Tam5YMjJqUjh2UlhkUmRDMVhNSkg4VTNZT0JHOWpFX1Q1MHdiMlB6dEZnVDF5UTY1bWllSWdPS2tIRm9IYy1fNkdSSER3UTJNTkJDRVZUTm9ZaVVNRXZTZy02dWppVmpjY0sxUl8yMVZMa3RHcVN1UGdTTVJ2SUpKeDk2ZlJIXzI4VVVCbHhFODhxSDZDLTV1bDhaTjhvemRHdjlZQlZPeERZVUNyZEZpdm5LNTJuSTRFQWEtRHl3UUtrenVPS2hVY2czaUhpcjJvOFFCTHZoeGpKR1FhRlItbXBEcndHMmE4cWJvSmlObkhESFgwemlJNXlHUGhlcEFpQm5GdVlFUQ?oc=5","date":"2023-02-15","type":"pipeline","source":"PR Newswire","summary":"Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound - PR Newswire","headline":"Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPakRRbV9KVlVWTV9NeGc3VUNOOUV3QXJVSGlwRUVjRmhleG5sNm9fTjBiRWo2c01FN01NZGRXNFhiRVRqVlhael8zbE03ejdna1h4THhQeWs4eS1FSUZ2X2wzMmItQUZ4eTd2RjNDVVI0aEtUWElnd0ItTzJkTXoyZUczZGhhME5sLVFpd0FKNDVwZkRCZGd4U25Oa3laenIyQnhz?oc=5","date":"2022-10-24","type":"pipeline","source":"SciTechDaily","summary":"Naturally Occurring Metabolite Identified That Converts “Bad” Fat to “Good” Fat - SciTechDaily","headline":"Naturally Occurring Metabolite Identified That Converts “Bad” Fat to “Good” Fat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxNOExZbXlBUHNRRFlyaUJIWS1LZ0dtcU9Ddk5OVFZRS1hQcHhqS3A5OUNlR194RkJBSDRqQmxVajlMd2pPVEh6U0gzaDkta2dYY0x5QUo4aHRKR0kyMjNDYnhuVlI0UnBLeVlJbEE4Sy05UlVjS1JaemR3RE5pZ1dmam9zd0tjV0MyQ3FkU0U2eEhFNmZieXlsSTFWVWt3d3VCR3gzTXJmRFI1NGoxU1dqQl90VnhkZGJMNmxIVmZWSlp4cWNMWDB2S3gxb3ozR2t3MTA1WkxiU21ueXpu?oc=5","date":"2020-06-05","type":"deal","source":"healthpolicy-watch.news","summary":"GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics - healthpolicy-watch.news","headline":"GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics - healt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPT2tPajJaSnVIOXdmNTI5cGZVeVRNUUNkYmo1bW15WkdmWGV5VkZSTHRINWpPb2M5UDdnNW1GTjU5ZWI5dkp1WElSUWZ5Z2xfQVA0anVXZG1NcExLZkwtVzNIbjhVR3dGSWFjUVVGYUFzQzlfdFUxZFpRUEdraFNuWHc1M0x3b2pxUW9DX1ZNeVQ0VFlxZ3VTb0lGazgyaWN5UWJNbw?oc=5","date":"2020-04-16","type":"pipeline","source":"Scripps Research","summary":"Scripps Research expands international effort to rapidly repurpose existing drugs against COVID-19 - Scripps Research","headline":"Scripps Research expands international effort to rapidly repurpose existing drugs against COVID-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNVGxWOXVMLWl6Tnp6LUNkWm1QNDBRUVc1SWF4WkxpdTd6elFyRENVZ3NEZmJiZmJ0WFptNDk0eHhxdGh6ekZnbklaY195SlVEQlNoN1h4NGRrUHJNaGdlazhZckNLVkZqMC15TjhiWHlTTEwxellUOUhLU1VZOFFGaFJMM1dnSU9hbjJOc3dILWVOSVB4LTgw?oc=5","date":"2019-03-26","type":"pipeline","source":"Scripps Research","summary":"Trio of new medicines originate from Scripps Research discoveries - Scripps Research","headline":"Trio of new medicines originate from Scripps Research discoveries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPdEJjaThOUGlnNVRNZlVCck9fdl9lOUIxWDhXdk84d3pJZFlaay1QTGQ3SkF4YWVyNk9qRjdObUI5WDVvZk1EYmlUY2pnQUZ1U2JRNVVIblpQWGJLelotQThYZDBJeldEejB4RHpSeTRfSWozTWRqaFpzVnNmUVNaSmRkOE9KczZkcW1Bdlk0aUpmYlZHcjZONUxPQUliNnc2N2tFd3QzTzdvbU1pR3h4NjF4ck5CWHBJaUw0MHNXaGd4NFpaMmY2UV9uWHk?oc=5","date":"2012-03-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Merck & Co. to Invest $90M to Set Up New Translational Med Center in San Diego - Genetic Engineering and Biotechnology News","headline":"Merck & Co. to Invest $90M to Set Up New Translational Med Center in San Diego","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}